Germline prokineticin receptor 2 (PROKR2) variants associated with central hypogonadism cause differental modulation of distinct intracellular pathways

Domenico Vladimiro Libri, Gunnar Kleinau, Valeria Vezzoli, Marta Busnelli, Fabiana Guizzardi, Antonio Agostino Sinisi, Angela Ida Pincelli, Antonio Mancini, Gianni Russo, Paolo Beck-Peccoz, Sandro Loche, Claudio Crivellaro, Mohamad Maghnie, Csilla Krausz, Luca Persani, Marco Bonomi

Research output: Contribution to journalArticle

Abstract

Introduction: Defects of prokineticin pathway affect the neuroendocrine control of reproduction, but their role in the pathogenesis of central hypogonadism remains undefined, and the functional impact of the missense PROKR2 variants has been incompletely characterized. Material and Methods: In a series of 246 idiopathic central hypogonadism patients,wefound three novel (p.V158I, p.V334M, and p.N15TfsX30) and six already known (p.L173R, p.T260M, p.R268C, p.V274D, p.V331M, and p.H20MfsX23) germline variants in the PROKR2 gene. We evaluated the effects of seven missense alterationsontwodifferent prokineticin receptor 2 (PROKR2)-dependent pathways: inositol phosphate-Ca2+ (Gq coupling) and cAMP (Gs coupling). Results: PROKR2 variants were found in 16 patients (6.5%). Expression levels of variants p.V158I and p.V331M were moderately reduced, whereas they were markedly impaired in the remaining cases, except p.V334M, which was significantly overexpressed. The variants p.T260M, p.R268C, and p.V331M showed no remarkable changes in cAMP response (EC50) whereas the IP signaling appeared more profoundly affected. In contrast, cAMP accumulation cannot be stimulated through the p.L173R and p.V274D, but IP EC50 was similar to wt inp.L173R and increased by 10-fold in p.V274D. The variant p.V334M led to a 3-fold increase of EC50 for both cAMP and IP. Conclusion: Our study shows that single PROKR2 missense allelic variants can either affect both signaling pathways differently or selectively. Thus, the integrity of both PROKR2-dependent cAMP and IP signals should be evaluated for a complete functional testing of novel identified allelic variants.

Original languageEnglish
JournalJournal of Clinical Endocrinology and Metabolism
Volume99
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Hypogonadism
Modulation
Inositol Phosphates
Reproduction
Genes
Defects
Testing

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Germline prokineticin receptor 2 (PROKR2) variants associated with central hypogonadism cause differental modulation of distinct intracellular pathways. / Libri, Domenico Vladimiro; Kleinau, Gunnar; Vezzoli, Valeria; Busnelli, Marta; Guizzardi, Fabiana; Sinisi, Antonio Agostino; Pincelli, Angela Ida; Mancini, Antonio; Russo, Gianni; Beck-Peccoz, Paolo; Loche, Sandro; Crivellaro, Claudio; Maghnie, Mohamad; Krausz, Csilla; Persani, Luca; Bonomi, Marco.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 99, No. 3, 2014.

Research output: Contribution to journalArticle

Libri, DV, Kleinau, G, Vezzoli, V, Busnelli, M, Guizzardi, F, Sinisi, AA, Pincelli, AI, Mancini, A, Russo, G, Beck-Peccoz, P, Loche, S, Crivellaro, C, Maghnie, M, Krausz, C, Persani, L & Bonomi, M 2014, 'Germline prokineticin receptor 2 (PROKR2) variants associated with central hypogonadism cause differental modulation of distinct intracellular pathways', Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 3. https://doi.org/10.1210/jc.2013-2431
Libri, Domenico Vladimiro ; Kleinau, Gunnar ; Vezzoli, Valeria ; Busnelli, Marta ; Guizzardi, Fabiana ; Sinisi, Antonio Agostino ; Pincelli, Angela Ida ; Mancini, Antonio ; Russo, Gianni ; Beck-Peccoz, Paolo ; Loche, Sandro ; Crivellaro, Claudio ; Maghnie, Mohamad ; Krausz, Csilla ; Persani, Luca ; Bonomi, Marco. / Germline prokineticin receptor 2 (PROKR2) variants associated with central hypogonadism cause differental modulation of distinct intracellular pathways. In: Journal of Clinical Endocrinology and Metabolism. 2014 ; Vol. 99, No. 3.
@article{e7c6231ee7d14424831eaec8e02226f6,
title = "Germline prokineticin receptor 2 (PROKR2) variants associated with central hypogonadism cause differental modulation of distinct intracellular pathways",
abstract = "Introduction: Defects of prokineticin pathway affect the neuroendocrine control of reproduction, but their role in the pathogenesis of central hypogonadism remains undefined, and the functional impact of the missense PROKR2 variants has been incompletely characterized. Material and Methods: In a series of 246 idiopathic central hypogonadism patients,wefound three novel (p.V158I, p.V334M, and p.N15TfsX30) and six already known (p.L173R, p.T260M, p.R268C, p.V274D, p.V331M, and p.H20MfsX23) germline variants in the PROKR2 gene. We evaluated the effects of seven missense alterationsontwodifferent prokineticin receptor 2 (PROKR2)-dependent pathways: inositol phosphate-Ca2+ (Gq coupling) and cAMP (Gs coupling). Results: PROKR2 variants were found in 16 patients (6.5{\%}). Expression levels of variants p.V158I and p.V331M were moderately reduced, whereas they were markedly impaired in the remaining cases, except p.V334M, which was significantly overexpressed. The variants p.T260M, p.R268C, and p.V331M showed no remarkable changes in cAMP response (EC50) whereas the IP signaling appeared more profoundly affected. In contrast, cAMP accumulation cannot be stimulated through the p.L173R and p.V274D, but IP EC50 was similar to wt inp.L173R and increased by 10-fold in p.V274D. The variant p.V334M led to a 3-fold increase of EC50 for both cAMP and IP. Conclusion: Our study shows that single PROKR2 missense allelic variants can either affect both signaling pathways differently or selectively. Thus, the integrity of both PROKR2-dependent cAMP and IP signals should be evaluated for a complete functional testing of novel identified allelic variants.",
author = "Libri, {Domenico Vladimiro} and Gunnar Kleinau and Valeria Vezzoli and Marta Busnelli and Fabiana Guizzardi and Sinisi, {Antonio Agostino} and Pincelli, {Angela Ida} and Antonio Mancini and Gianni Russo and Paolo Beck-Peccoz and Sandro Loche and Claudio Crivellaro and Mohamad Maghnie and Csilla Krausz and Luca Persani and Marco Bonomi",
year = "2014",
doi = "10.1210/jc.2013-2431",
language = "English",
volume = "99",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Germline prokineticin receptor 2 (PROKR2) variants associated with central hypogonadism cause differental modulation of distinct intracellular pathways

AU - Libri, Domenico Vladimiro

AU - Kleinau, Gunnar

AU - Vezzoli, Valeria

AU - Busnelli, Marta

AU - Guizzardi, Fabiana

AU - Sinisi, Antonio Agostino

AU - Pincelli, Angela Ida

AU - Mancini, Antonio

AU - Russo, Gianni

AU - Beck-Peccoz, Paolo

AU - Loche, Sandro

AU - Crivellaro, Claudio

AU - Maghnie, Mohamad

AU - Krausz, Csilla

AU - Persani, Luca

AU - Bonomi, Marco

PY - 2014

Y1 - 2014

N2 - Introduction: Defects of prokineticin pathway affect the neuroendocrine control of reproduction, but their role in the pathogenesis of central hypogonadism remains undefined, and the functional impact of the missense PROKR2 variants has been incompletely characterized. Material and Methods: In a series of 246 idiopathic central hypogonadism patients,wefound three novel (p.V158I, p.V334M, and p.N15TfsX30) and six already known (p.L173R, p.T260M, p.R268C, p.V274D, p.V331M, and p.H20MfsX23) germline variants in the PROKR2 gene. We evaluated the effects of seven missense alterationsontwodifferent prokineticin receptor 2 (PROKR2)-dependent pathways: inositol phosphate-Ca2+ (Gq coupling) and cAMP (Gs coupling). Results: PROKR2 variants were found in 16 patients (6.5%). Expression levels of variants p.V158I and p.V331M were moderately reduced, whereas they were markedly impaired in the remaining cases, except p.V334M, which was significantly overexpressed. The variants p.T260M, p.R268C, and p.V331M showed no remarkable changes in cAMP response (EC50) whereas the IP signaling appeared more profoundly affected. In contrast, cAMP accumulation cannot be stimulated through the p.L173R and p.V274D, but IP EC50 was similar to wt inp.L173R and increased by 10-fold in p.V274D. The variant p.V334M led to a 3-fold increase of EC50 for both cAMP and IP. Conclusion: Our study shows that single PROKR2 missense allelic variants can either affect both signaling pathways differently or selectively. Thus, the integrity of both PROKR2-dependent cAMP and IP signals should be evaluated for a complete functional testing of novel identified allelic variants.

AB - Introduction: Defects of prokineticin pathway affect the neuroendocrine control of reproduction, but their role in the pathogenesis of central hypogonadism remains undefined, and the functional impact of the missense PROKR2 variants has been incompletely characterized. Material and Methods: In a series of 246 idiopathic central hypogonadism patients,wefound three novel (p.V158I, p.V334M, and p.N15TfsX30) and six already known (p.L173R, p.T260M, p.R268C, p.V274D, p.V331M, and p.H20MfsX23) germline variants in the PROKR2 gene. We evaluated the effects of seven missense alterationsontwodifferent prokineticin receptor 2 (PROKR2)-dependent pathways: inositol phosphate-Ca2+ (Gq coupling) and cAMP (Gs coupling). Results: PROKR2 variants were found in 16 patients (6.5%). Expression levels of variants p.V158I and p.V331M were moderately reduced, whereas they were markedly impaired in the remaining cases, except p.V334M, which was significantly overexpressed. The variants p.T260M, p.R268C, and p.V331M showed no remarkable changes in cAMP response (EC50) whereas the IP signaling appeared more profoundly affected. In contrast, cAMP accumulation cannot be stimulated through the p.L173R and p.V274D, but IP EC50 was similar to wt inp.L173R and increased by 10-fold in p.V274D. The variant p.V334M led to a 3-fold increase of EC50 for both cAMP and IP. Conclusion: Our study shows that single PROKR2 missense allelic variants can either affect both signaling pathways differently or selectively. Thus, the integrity of both PROKR2-dependent cAMP and IP signals should be evaluated for a complete functional testing of novel identified allelic variants.

UR - http://www.scopus.com/inward/record.url?scp=84895786097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895786097&partnerID=8YFLogxK

U2 - 10.1210/jc.2013-2431

DO - 10.1210/jc.2013-2431

M3 - Article

C2 - 24276467

AN - SCOPUS:84895786097

VL - 99

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 3

ER -